Immune & Inflammatory

The immune & inflammatory disease portfolio offers world-class analysis of drug markets that are among the most commercially successful. The emergence of breakthrough, high-cost, biological therapies has resulted in considerable market growth for these disease states.  Our research products provide clients with powerful insights on the unique reimbursement and competitive risks and opportunities associated with this therapeutic area.

Some of the most in-demand reports are in the Immune & Inflammatory disease portfolio such as:

• Crohn's Disease: Physician and Payer Acceptance of Early Biologics Use
• Psoriatic Arthritis
• Asthma
• Emerging Therapies in Rheumatoid Arthritis

Upcoming immune & inflammatory disease reports:

• Psoriasis
• Systemic Lupus Erythematosus
• Emerging Rheumatoid Arthritis Therapies

If you don't find a topic or disease in our list of publications, please call (toll free in the U.S.: +1-866-296-8352) or email  us so that we can guide you to related or upcoming coverage or discuss a customized project through our consulting group.